Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, Dec. 27, 2024 -- A blood transfusion following a heart attack could be a life-saving measure for patients with anemia.
A new evidence review published in the journal NEJM Evidence shows anemic patients had a slightly lower risk of death within six months of a heart attack if they were given more transfusions.
“The results of this analysis show that giving more blood to anemic patients with heart attacks can save lives at six months,” lead researcher Dr. Jeffrey Carson, chair of general internal medicine at Rutgers Robert Wood Johnson Medical School, said in a news release from the college.
Anemia is common among people hospitalized with a heart attack, Carson said. In anemia, a person’s blood can’t transport enough oxygen to the rest of the body.
Some doctors have speculated that blood transfusions might increase the amount of oxygen to the heart, improving heart attack patients’ chances of survival, Carson said.
However, transfusions might also increase the risk of infection or fluid buildup in these patients.
For this new study, researchers pooled data from four clinical trials evaluating transfusions in heart attack patients. The trials involved more than 4,300 patients who had both a heart attack and a low blood count, which is a sign of anemia.
In the trials, half of the patients received fewer blood transfusions, and the other half received more.
About 9.3% of patients who got fewer blood transfusions died within 30 days of their heart attack, compared with 8.1% of patients who were treated with more transfusions, results show.
Specifically, heart-related death within 30 days occurred in 5.5% of patients with fewer transfusions and 3.7% of patients who got more, the study says.
Overall, the risk of death or a second heart attack was about 2.4% lower in patients who received more blood transfusions, researchers found.
However, the results don’t definitively establish that more transfusions are better, because the main findings weren’t statistically significant, researchers noted.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-28 00:00
Read more
- Preferential Promotion of White Men Persisting in Academic Medicine
- Life Expectancy Increased From 2022 to 2023, Reaching 78.4 Years
- GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes
- Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm (epinephrine) Sublingual Film
- Long-Term Exposure to Air Pollution Tied to More Hospital Admissions
- Rilzabrutinib Demonstrated Significant Patient Benefit in the First Positive Phase 3 Study of a BTK Inhibitor in ITP
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions